Kelly Conlon PhD
Dr Kelly Conlon is a non clinical development specialist with more than 20 years experience leading projects from early discovery through to clinical transition. Kelly has a PhD in Physiology and is a Fellow of the Royal Society of Biology. Prior to joining Midatech in 2017, Kelly held senior positions at Astra Zeneca, Shire Pharmaceuticals and Pfizer. In addition to leading a number of Midatech’s early discovery projects, Kelly provides translational medicine support across the Midatech portfolio.